Vaxart, Inc. (VXRT)
0.4344
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Vaxart EPS Diluted (Quarterly) : -0.0557 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0557 |
| March 31, 2026 | 0.0214 |
| December 31, 2025 | 0.2289 |
| September 30, 2025 | -0.0356 |
| June 30, 2025 | -0.0656 |
| March 31, 2025 | -0.0684 |
| December 31, 2024 | -0.0526 |
| September 30, 2024 | -0.0619 |
| June 30, 2024 | -0.0891 |
| March 31, 2024 | -0.1446 |
| December 31, 2023 | -0.1132 |
| September 30, 2023 | -0.1144 |
| June 30, 2023 | -0.1615 |
| March 31, 2023 | -0.1859 |
| December 31, 2022 | -0.1805 |
| September 30, 2022 | -0.231 |
| June 30, 2022 | -0.2328 |
| March 31, 2022 | -0.1995 |
| December 31, 2021 | -0.1655 |
| September 30, 2021 | -0.1418 |
| June 30, 2021 | -0.1333 |
| March 31, 2021 | -0.1387 |
| December 31, 2020 | -0.1264 |
| September 30, 2020 | -0.0751 |
| June 30, 2020 | -0.1202 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0214 |
| December 31, 2019 | -0.1342 |
| September 30, 2019 | -0.3237 |
| June 30, 2019 | -0.3862 |
| March 31, 2019 | -0.1834 |
| December 31, 2018 | -0.6864 |
| September 30, 2018 | -0.9169 |
| June 30, 2018 | -1.242 |
| March 31, 2018 | 0.487 |
| June 30, 2017 | -1.65 |
| March 31, 2017 | -1.21 |
| December 31, 2016 | -2.64 |
| September 30, 2016 | -2.86 |
| June 30, 2016 | -1.98 |
| March 31, 2016 | -1.480 |
| December 31, 2015 | -1.87 |
| September 30, 2015 | -1.87 |
| June 30, 2015 | -6.05 |
| March 31, 2015 | 0.33 |
| December 31, 2014 | 2.09 |
| September 30, 2014 | -2.20 |
| June 30, 2014 | -3.19 |
| March 31, 2014 | 0.99 |
| December 31, 2013 | -0.0388 |
| September 30, 2013 | -1.54 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.49M |
| Revenue (Quarterly) | 27.18M |
| Total Expenses (Quarterly) | 40.68M |
| Enterprise Value | 54.05M |
| Gross Profit Margin (Quarterly) | 97.27% |
| Profit Margin (Quarterly) | -49.64% |
| Earnings Yield | 36.60% |
| Operating Earnings Yield | 38.24% |
| Normalized Earnings Yield | 36.60 |